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Neuropsychological group study methodology is considered one of the primary methods to further
understanding of the organisation of frontal ‘executive’ functions. Typically, patients with frontal lesions
caused by stroke or tumours have been grouped together to obtain sufﬁcient power. However, it has been
debated whether it is methodologically appropriate to group together patients with neurological lesions
of different aetiologies. Despite this debate, very few studies have directly compared the performance of
patients with different neurological aetiologies on neuropsychological measures. The few that did in-
cluded patients with both anterior and posterior lesions.
We present the ﬁrst comprehensive retrospective comparison of the impact of lesions of different
aetiologies on neuropsychological performance in a large number of patients whose lesion solely affects
the frontal cortex. We investigated patients who had a cerebrovascular accident (CVA), high (HGT) or low
grade (LGT) tumour, or meningioma, all at the post-operative stage. The same frontal ‘executive’ (Raven's
Advanced Progressive Matrices, Stroop Colour-Word Test, Letter Fluency-S; Trail Making Test Part B) and
nominal (Graded Naming Test) tasks were compared. Patients' performance was compared across ae-
tiologies controlling for age and NART IQ scores. Assessments of focal frontal lesion location, lesion
volume, global brain atrophy and non-speciﬁc white matter (WM) changes were undertaken and com-
pared across the four aetiology.
We found no signiﬁcant difference in performance between the four aetiology subgroups on the
‘frontal’ executive and nominal tasks. However, we found strong effects of premorbid IQ on all cognitive
tasks and robust effects of age only on the frontal tasks. We also compared speciﬁc aetiology subgroups
directly, as previously reported in the literature. Overall we found no signiﬁcant differences in the per-
formance of CVA and tumour patients, or LGT and HGT patients or LGT, HGT and meningioma's on our
four frontal tests. No difference was found with respect to the location of frontal lesions, lesion volume,
global brain atrophy and non-speciﬁc WM changes between the subgroups.
Our results suggest that the grouping of frontal patients caused by different aetiologies is a pragmatic,
justiﬁed methodological approach that can help to further understanding of the organisation of frontal
executive functions.
& 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Neuropsychological group study methodology is considered
one of the primary methods to further understanding of the25
r Ltd. This is an open access article
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4484761.neuroanatomical architecture underlying cognitive functions.
However, to obtain sufﬁcient power with this methodology it is
necessary to recruit rather large numbers of neurological patients.
If too few patients are used, the results are inevitably inconclusive.
Thus, to investigate neuro-cognitive architectures, patients with
different aetiologies such as vascular (CVA) or tumour (different
types of brain tumours) are often combined. A typical example of
this approach is given by research investigating the organisation of
frontal ‘executive’ functions. Different aspects of executiveunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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patients with frontal lesions caused by stroke or tumours. Thus,
Stuss et al. (2003) investigated a measure of executive control
combining patients with CVA (n¼19) and patients with either
tumour or lobectomy (n¼12). Roca et al. (2010) investigated ﬂuid
intelligence and executive functions in a group which combined 11
CVA and 31 tumour patients. Robinson et al. (2012) investigated
verbal generation in a group combining 15 CVA and 52 tumour
patients.
However, it is well known that stroke and tumours affect brain
structures in several different ways. For example, CVAs such as
ischaemic stroke causes cell death within the affected area. In
contrast, neural activity can persist in areas inﬁltrated by low
grade tumours (e.g. Krainik et al., 2003). The onset of a CVA is
deﬁned by an acute event; the rate of brain tumour growth can
vary dramatically by grading (see, e.g. Jääskeläinen et al., 1985;
Kleihues et al., 2007, p. 36). Physical changes in brain structures
resulting from different grades of brain tumour are not equivalent.
For example, low grade tumours and meningioma's are likely to
compress adjacent brain structures (Perry et al., 2007). In contrast,
high grade tumours such as glioblastomas are likely to invade
cortical or subcortical structures (Kleihues et al., 2007). These
fundamental differences raise the possibility that CVA, high grade
tumours, low grade tumours and meningioma's may recruit me-
chanisms of neural plasticity in different ways leading to different
functional outcomes.
In the literature it has been debated if, for the purpose of
neuropsychological investigation, the grouping together of pa-
tients with different neurological aetiologies is methodologically
appropriate (e.g. Duffau, 2011: Clinical Neuroanatomy, discussion
forum, Cortex). For example, Anderson et al. (1990) argued that as
far as stroke and tumour patients are concerned “…the two pa-
tient types should be treated separately for the purpose of neu-
ropsychological research”. Karnath and Steinbach (2011) focused
on tumour patients (unilateral gliomas or meningiomas) and ar-
gued that neuropsychological investigation should not “…use pa-
tients with tumours to identify the ‘critical lesion sites’ related to a
certain disorder, in particular if the more general aim is to de-
termine the neural representation of this function in the human
brain…” (p. 1005). In contrast, Shallice et al. (2010) reported that
patients with different aetiologies give rise to the same localisa-
tion of a critical function (for example see Brambati et al. (2006)
and Campanella et al. (2010), naming of non-living objects).
Despite this debate, very few studies have directly compared
the performance of patients with different neurological aetiologies
on neuropsychological measures. Only Anderson et al. (1990) have
compared stroke and tumour patients and attempted to control for
lesion location. The authors investigated the neuropsychological
performance of a relatively small sample of stroke (n¼19; 10 left,
9 right) and tumour (8 left, 9 right; glioma, grade unknown n¼15;
meningioma n¼2) patients. Using mainly CT scans, the in-
vestigators attempted to match anatomically the patients for le-
sion size and location on a case-by-case basis. The authors re-
ported that the left stroke patients performed signiﬁcantly worse
than the left tumour patients on 4/6 subtests from the Multilingual
Aphasia Examination battery. For right hemisphere patients, dif-
ferences were less clear cut (see Shallice et al. (2010) for
discussion).
Other studies have investigated whether patients with high
and low grade tumours differ in terms of neuropsychological test
performance (Hom and Reitan, 1984; Hahn et al., 2003). Un-
fortunately, the effect of lesion location at a ﬁner level than the
hemisphere has generally not been reported. In an older study,
Hom and Reitan (1984) compared patients with high grade tu-
mours (gradeZ3, n¼46) and with low-grade tumours (grader2,
n¼46) on the WAIS-III and Halstead–Reitan battery. High gradeperformed worse than low grade tumour patients on the WAIS-III
and almost all the subtests of the Halstead–Reitan battery. Simi-
larly, Hahn et al. (2003) reported that high grade (n¼31) per-
formed signiﬁcantly poorer than low grade tumour patients
(n¼37) on two out of ten neuropsychological measures (Trail-
Making Test Part A, COWAT FAS). Shallice et al. (2010) studied the
effect of type of tumour on four different ‘right parietal’ tests. They
investigated high grade tumour patients (n¼25), low grade tu-
mour patients (n¼28) and meningioma patients (n¼15). The au-
thors reported that in two of the four tests, high grade tumour
patients performed signiﬁcantly worse than low grade tumour
patients post-operatively. However, there was a signiﬁcant post-
operative decline in three tests in the low grade tumour group.
In contrast, other studies have reported no signiﬁcant differ-
ences between high and low grade tumour patients on extensive
batteries of tests. Scheibel et al. (1996) contrasted patients with
highly malignant glioblastomas (grade 4, n¼106) and less malig-
nant gliomas (grader3, n¼139), with all patients at the post-
operative stage. No effect of tumour malignancy was found, al-
though signiﬁcant effects for tumour lateralisation and type of
therapy (radiotherapy, resection or both) were reported. Talacchi
et al. (2011) also documented no signiﬁcant difference in perfor-
mance in a small number of high and low grade post-operative
tumour patients (N¼17 and N¼12, respectively).
It should be noted that none of the studies reviewed above
attempted a comprehensive comparison between aetiologies, such
as vascular and different type and grades of tumours. It is often
unclear whether studies reporting on tumour patients were tested
at the pre-operative or post-operative stage. All previous studies
have included patients with both anterior and posterior lesions.
Moreover, most did not characterize lesion location at a ﬁner level
than the damaged hemisphere, the only exception being the study
by Shallice et al. (2010). Lesion size comparisons have only been
documented by the Anderson et al. (1990) study using mainly CT
scans. Interestingly, only some of the studies have analysed and
corrected for the effect of age (Hahn et al., 2003; Scheibel et al.,
1996). Others have not and yet reported difference between the
age of the aetiology groups (e.g. CVA patients older than tumour
patients, Anderson et al., 1990; high grade glioma patients older
than low grade glioma patients, Hom and Reitan, 1984).
The aim of our retrospective study was to carry out the ﬁrst
comprehensive comparison of the impact of different aetiologies
on neuropsychological performance. We reviewed a large number
of patients with CVA; high and low grade tumours as well as
meningiomas, all at the post-operative stage. The lesions of all
patients were unilateral and conﬁned to the frontal lobes. We
determined the location of the frontal lesions and for a subsample
of patients the total lesion volume. Measures of global atrophy and
white matter (WM) changes were also undertaken. We compared
the performance of the frontal patients on the same frontal ‘ex-
ecutive’ and nominal tasks across the aetiologies whilst taking into
account differences in age and premorbid levels of functioning.
Apriori comparisons of speciﬁc aetiologies groups were also con-
ducted. Using these we sought to investigate further the ﬁndings
of previous studies (Anderson et al., 1990; Hom and Reitan, 1984).2. Materials and methods
2.1. Participants
One hundred and sixty four patients with a unilateral lesion
conﬁned to the frontal lobes resulting from a cerebrovascular ac-
cident (CVA) or a brain tumour, attending the Neuropsychology
Department at the National Hospital for Neurology and Neuro-
surgery, Queen Square, London, were retrospectively screened for
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current or previous psychiatric disorders, (iii) current or previous
neurological disorders including previous CVAs or tumours, (iv)
presence of metastatic tumours, (v) previous chemotherapy, (vi)
visual or motor impairment, (vii) previous head trauma, (viii)
history of excessive alcohol or drug use, (ix) no MRI or CT scan
results available, (x) no neuropsychological assessment available,
(xi) a score below the 5th percentile on a test of general in-
telligence (WAIS-III, WAIS-R or Raven's Matrices), (xii) gross per-
ceptual or language impairment. Non-native English speakers
were only included in the study if they obtained a score at or
above the 25th percentile on the National Adult Reading Test
(NART, Nelson, 1982).
Application of the exclusion criteria resulted in 100 patients
being retrospectively included in the study. For all patients the
diagnosis was conﬁrmed by neurological investigation. Tumour
grade was conﬁrmed by histopathological studies following re-
section or biopsy. All tumour patients had undergone tumour re-
section prior to neuropsychological assessment. Patients were as-
signed to four groups based on lesion aetiology; the CVA group
(n¼29), the low grade tumour group (LGT, tumour grader2,
n¼24), the high grade tumour group (HGT, tumour gradeZ3,
n¼20) and the meningioma group (n¼27).
Retrospective recruitment of patients was approved by the
National Hospital for Neurology and Neurosurgery and the In-
stitute of Neurology Joint Research Ethics Committee (UK). Fifty
three patients with frontal lesions included in this study have had
aspects of their proﬁles reported previously (MacPherson et al.,
2008, 2010; Murphy et al., 2013; Robinson et al., 2012; Turner
et al., 2007).
2.2. Neuroimaging analysis
Both MRI and CT data were used, as our principal goal was to
recruit a large number of patients. Hard copies or digital records of
all scans were reviewed by two independent neurologists (MB and
BS) who were blind to the medical history of each patient. For 95
out of 100 patients MRI (n¼76; n¼5 hard copies) or CT scan
(n¼19) were available for analysis. Digital brain MRI scans were
obtained on systems operated at .5 (n¼1) or 1.5 (n¼54) or 3
(n¼16) Tesla and included the acquisition of an axial dual-echo
and an axial and coronal T1-weighted scan. CT scans were ob-
tained using spiral CT systems. Axial images were collected with
an effective slice thickness of 5 mm and pitch of 1.5. Only T1-
weighted MRI scans (or CT scans when MRI was not available)
were used for the assessment of frontal lesions. We conducted an
analysis of the total frontal lesion volumes only for a subset of
patients. These were the patients for whom we obtained the lar-
gest number of MRI scans at the same magnetic strength (1.5 T).
DE and FLAIR images were used for the assessment of global brain
atrophy and non-speciﬁc WM changes.
2.2.1. Investigation of the frontal lesions
The exclusion criteria and lesion assessment guidelines were
rigorous and based on detailed anatomical localisation using
standard atlases (Duvernoy et al., 1991). Of note, all frontal lesions
had to be entirely located within the frontal lobe. The lesion lo-
calisation method is described in detail in Robinson et al. (2012)
and Murphy et al. (2013). Brieﬂy, each frontal patient was coded
for the presence of lesion and oedema in each hemisphere in the
anterior and posterior portion of nine left and nine right frontal
subregions (18 subregions in total). A subregion was only coded as
damaged if at least 25% was affected. To compare whether left or
right frontal lobe lesion differentially impact on cognitive perfor-
mance across the four aetiologies, we merged the nine left and
right brain subregions, and divided the patients into two groups:left and right frontal according to which hemisphere was
damaged.
To investigate whether across the four aetiologies there were
differences in the number of patients with lesions in different
areas of the frontal lobe we employed the grouping method de-
scribed by Stuss et al. (1998), Stuss and Alexander (2005) and
adopted in our previous studies (e.g. Murphy et al., 2013; Mac-
Pherson et al., 2010; Robinson et al., 2012). Lesions in prefrontal
subregions were grouped together to deﬁne a primary lesion site
of one of four main subgroups: medial, left lateral, right lateral and
orbitofrontal. For these four areas the primary lesion site was
deﬁned as either (a) damage restricted to the cortical subregions
that deﬁned the area or (b) damage affecting at least three cortical
subregions used to deﬁne each area and no more than one other
subregion (secondary site) belonging to an adjacent area. Ac-
cording to this criterion, one frontal patient only was excluded
from this analysis as the criteria for the primary lesion site ﬁt more
than one subgroup. Patients with unilateral primary damage to the
medial area had lesions affecting the left/right cingulate gyrus
(anterior/posterior), the left/right sub-genu, and the left/right
medial and superior frontal gyrus (anterior/posterior). These
frontal subregions correspond to the following Brodmann areas: 6,
8, 9, 10, 23, 24, 32 and 33. Patients with damage to the lateral areas
(left or right) had lesions affecting the left or right lateral part of
the superior frontal gyrus (anterior/posterior), the left or right
middle frontal gyrus (anterior/posterior), and the left or right in-
ferior frontal gyrus (anterior/posterior). These subregions corre-
spond to the Brodmann areas: 6, 8, 9, 38, 44, 45, 46 and 47. Finally,
patients with brain damage to the orbitofrontal area had lesions
affecting the left and right orbital cortex (Brodmann areas 10 and
11).
2.2.2. Volumetric investigation of frontal lesions
A volumetric lesion analysis was conducted on the subsample
of 54 patients who had a digital 1.5 T MRI scan. Two of these pa-
tients were removed due to movement artefacts. In all patients
hypointense lesions were outlined on the T1-weighted MRI slices
using a semi-automated local thresholding contouring software
(Jim 5.0, Xinapse System, Leicester, UK, http://www.xinapse.com/).
The total lesion volume was then calculated for every patient.
2.2.3. Investigation of brain atrophy
Visual quantiﬁcation of global brain atrophy was assessed using
FLAIR or CT scans, according to the method proposed by Scheltens
et al. (1997). Scores ranged from 0¼absence of atrophy;
1¼minimal atrophy; 2¼moderate atrophy; to 3¼severe atrophy.
Intra- and inter-observer variability in quantifying atrophy was
tested and no signiﬁcant differences were observed.
2.2.4. Investigation of white matter changes
To visually quantify WM changes we used the Fazekas' rating
scale (Fazekas et al., 1987), which is widely used in the literature. It
includes 2 sub-scales; periventricular WM changes (i.e. PVH sub-
scale) and deep WM changes (i.e. DWMH sub-scale). For MRI
scans, WM changes are deﬁned as hyper-intense areas, detectable
on DE and/or FLAIR images. For CT scans, WM changes are deﬁned
as hypo-dense areas within the WM. Scores range from 0 – ab-
sence of WM changes to 3 – most severe degree of WM changes.
2.3. Neuropsychological investigation
The neuropsychological battery comprised a series of widely
used clinical tests with published standardised normative data
collected from large control samples. The National Adult Reading
Test (NART) was given to estimate optimal pre-morbid levels of
functioning (Nelson, 1982). The results from four further
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L
H
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CVARaven's Advanced Progressive Matrices (RAPM; Raven, 1965),
an untimed, relatively culture-free, non-verbal test of abstract
reasoning, requiring the selection of the missing piece from a
pattern. The total number of correct responses in Set I was
recorded.2. Stroop Test (Trenerry et al., 1989), a test of response inhibition.
The total number of colour words for which the colour was
correctly named in two minutes was recorded.3. Letter ﬂuency ‘S’ Test (FAS; Benton, 1968), a test of phonemic
ﬂuency, requiring the oral generation of words beginning with
the letter S. The total number of correct responses in one
minute was recorded.4. Trail Making Test, Part B (Reitan and Wolfson, 1985), a test of
task switching. The total completion time in seconds was
recorded.5. The Graded Naming Test (GNT; McKenna and Warrington
1980), a test of object naming. The total number of objects
correctly named was recorded.
2.4. Statistical analysis
All statistics were carried out using SPSS Statistics (http://
www-01.ibm.com/software/analytics/spss/).
2.4.1. Demographic variable analysis
The demographic variables were analysed using chi-square
analysis (handedness, gender) or an analysis of variance (ANOVA)
(age, NART and years of education). This was used to test for sig-
niﬁcant difference between the four aetiologies (CVA, HGT, LGT,
and meningioma).
2.4.2. Neuroimaging statistical analysis
Chi-square analysis (frontal lesions), one-way ANOVA (frontal
lesions volume) and Kruskal–Wallis non-parametric ANOVAs
(brain atrophy, WM changes) were used in the neuroimaging
analysis to test for signiﬁcant differences between the aetiology
subgroups. There was a signiﬁcant difference in variance between
aetiology subgroups in frontal lesion volumes. This was corrected
with a log10 transformation. To account for the two sub-scales
used in the WM analysis, Kruskal–Wallis non-parametric ANOVA
was corrected using a Bonferroni adjustment (po .025). Brain
atrophy and WM changes are known to be associated with aging
(e.g. Kim et al., 2011; de Leeuw et al., 2001). To examine the impact
of age on brain atrophy and WM changes, linear regression ana-
lyses were conducted on brain atrophy and WM rating scale using
age as predictor variable.
2.4.3. Neuropsychological statistical analysis
The neuropsychological ﬁndings were analysed to ascertain if
they were normally distributed and to identify outliers. Thele 1
ographic results.
roups Handedness
(L/R)
Gender
(M/F)
VA (n¼29) 4/25 16/13
GT (n¼24) 3/21 14/10
GT (n¼20) 2/18 13/7
eningioma
(n¼27)
4/23 11/16
¼stroke, LGT¼ low grade tumour, HGT¼high grade tumour, L¼ left, R¼right, M¼mﬁndings were also assessed for homogeneity of variance. Negative
skew was found for the GNT and the Stroop Test. This was cor-
rected using square root transformation (the square root of, the
maximum possible score plus one, minus each patient′s score). A
positive skew was found for Trail Making Part B. This was cor-
rected with a log10 transformation. All neuropsychological data
was analysed using ANCOVAs, with age and NART as covariates.
Partial eta squared was used to estimate the effects size for age,
NART IQ and aetiology. To investigate the effect of lateralisation,
patients were classiﬁed according to hemisphere damage (left
frontal lesion or right frontal lesion) and their neuropsychological
performance was examined. To investigate the effect of aetiology,
patients were classiﬁed according to their aetiology subgroups
(CVA, LGT, HGT and Meningioma) and their neuropsychological
performance was examined.
To examine the impact of the covariates on performance, linear
regression analysis was conducted on each of the frontal tasks
using age and NART as predictor variables. Additionally three
planned comparisons of speciﬁc aetiology subgroups, motivated
by previous studies, were carried out. Individual ANCOVAs were
used to compare the neuropsychological performance of (i) CVA
and one group including all tumour patients (LGT, HGT and me-
ningiomas combined; Anderson et al., 1990), (ii) LGT and HGT
(Hom and Reitan, 1984) and (iii) different tumour aetiologies (LGT,
HGT and meningioma patients). Age and NART IQ scores were used
as covariates in all analyses.3. Results
3.1. Demographic results
Demographic results for the four aetiology subgroups (CVA,
LGT, HGT and Meningioma) are shown in Table 1. No signiﬁcant
difference was found between patients for handedness, gender
and education. There was a signiﬁcant main effect of age (F(3,
96)¼10.581, po .001). Post hoc analysis revealed that the Me-
ningioma group were signiﬁcantly older than all other aetiology
subgroups (CVA, p¼ .009; LGT, po .001; HGT, p¼ .006) and there
was a trend for LGT to be somewhat younger then CVA (p¼ .09).
There was no signiﬁcant main effect of NART IQ (F(3, 91)¼1.882,
p4 .138).
3.2. Investigation of frontal lesions
T1-w MRI or CT scans were available for 94 out of the 95 pa-
tients. We compared the four aetiology subgroups on the number
of patients with focal brain damage in the four frontal areas. There
was no difference across the aetiology subgroups in the numbers
of patients with damage to medial (χ2(3, N¼94)¼5.929, p¼ .115),
left lateral (χ2(3, N¼94)¼1.569, p¼ .666), right lateral: (χ2(3,
N¼94)¼1.308, p¼ .727) and orbital frontal areas: (χ2(3, N¼94)¼
1.097, p¼ .778; see Fig. 1).Age (years)
mean (SD)
NART IQ mean
(SD)
Education
(years) mean
(SD)
46.59 (17.71) 107.15 (9.99) 14.07 (3.46)
37.78 (7.08) 112.30 (9.17) 14.25 (2.92)
44.95 (14.51) 104.16 (14.31) 14.3 (2.7)
58.19 (10.70) 108.48 (11.95) 13.78 (3.21)
ale, F¼female, N¼number, SD¼standard deviation.
Fig. 1. Percentage of patients with damage to the different frontal areas in each aetiology subgroup. The number of patients in each aetiology subgroup for whom we
analysed frontal lesion location. Shading illustrates the percentage of patients with damage to lateral (right and left), medial and orbito-frontal regions for each aetiology
subgroup. Abbreviations: CVA¼stroke; LGT¼ low grade tumour; HGT¼high grade tumour.
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Table 2
Mean and standard deviation of the aetiology subgroups on the severity of white
matter change.
Aetiology Fazekas' WM changes rating sub-scale
PVH mean DWMH mean
CVA (SD) .65 (.78) .17 (.39)
LGT (SD) .32 (.58) .11 (.32)
HGT (SD) .75 (.58) .13 (.34)
Meningioma (SD) 1.23 (.87) .68 (.89)
WM¼white matter; PVH¼periventricular hyper intensity scale; DWMH¼deep
white matter hyper intense/hypo dense signal scale; CVA¼stroke; LGT¼ low grade
tumour; HGT¼high grade tumour.
Table 3
Neuropsychological results: left and right frontal patients.
Measure LF (N¼44) RF (N¼56)
NART Mean Full Scale IQ (SD) 107.48 (13.58) 108.74 (9.68)
RAPM No Correct/12 (SD) 7.94 (2.60) 8.27 (2.72)
STROOP No of colours in 120 s (SD) 77.81 (26.91) 95.74 (22.92)
FLUENCY ‘S’ No of words in 60 s (SD) 9.78 (5.99) 13.55 (4.60)
Trails B No of seconds (SD) 96.21 (38.14) 91.61 (72.29)
GNT No Correct/30 (SD) 18.72 (4.68) 21.50 (4.48)
LF¼ left frontal, RF¼right frontal, No¼number, NART¼National Adult Reading Test,
RAPM¼Raven's Advanced Progressive Matrices, GNT¼Graded Naming Test,
N¼number of participants, s¼seconds and SD¼standard deviation presented in
parentheses.
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Volumetric analysis was available for 52 out of 95 patients
(CVA¼13, LGT¼16, HGT¼10 and meningioma¼13). We found no
signiﬁcant difference in the total frontal lesion volume between
the four aetiology subgroups F(3, 48)¼1.384, p¼ .259.
3.4. Investigation of brain atrophy
FLAIR or CT scans were available for 80 out of the 95 patients.
These were analysed using Scheltens et al. (1997) method of global
brain atrophy quantiﬁcation. A Kruskal–Wallis non-parametric
ANOVA indicated that there was no signiﬁcant difference across
the four aetiology subgroups (χ2(3, N¼80)¼4.633, p¼ .201). This
suggests that the amount of brain atrophy did not differ between
patients from different aetiology subgroups. A linear regression
analysis indicated that there was a signiﬁcant effect of age on the
increment scores on the brain atrophy rating scale (R2¼ .27, F(1,
87)¼32.13, po .001).
3.5. Investigation of white matter changes
DE, FLAIR or CT scans were available for 80 out of the 95 pa-
tients. These were analysed using the Fazekas' rating scale for the
quantiﬁcation of WM changes. Table 2 displays the means and
standard deviations of the scores of four aetiology subgroups on
the Fazekas sub-scales. Despite the rather high variability in the
scores, we found a signiﬁcant difference between the four aetiol-
ogy subgroups in both periventricular hyper/hypo intensity (PVH)
and deep white matter hyper/hypo intensity signal (DWMH) sub-
scales (PVH: χ2 (3, N¼80)¼13.843, p¼ .003; DWMH: χ2 (3,
N¼80)¼12.392, p¼ .006). Post-hoc pair-wise comparisons using
Mann–Whitney non parametric analysis indicated that these dif-
ferences were due to meningioma patients having more severe
white matter changes than the others patient subgroups (PVH:
LGT vs CVA: z¼9.598, p¼ .150; LGT vs HGT: z¼–14.003, p¼ .055;
LGT vs meningioma: z¼24.566, po .001; CVA vs HGT:
z¼4.405, p¼ .529; CVA vs meningioma: z¼14.967, p¼ .020;
HGT vs meningioma: z¼10.562, p¼ .135; DWMH: LGT vs HGT:
z¼ .770, p¼ .895; LGT vs CVA: z¼2.677, p¼ .615; LGT vs me-
ningioma: z¼16.258, p¼ .003; HGT vs CVA: z¼1.908, p¼ .733;
HGT vs meningioma: z¼15.489, p¼ .006; CVA vs meningioma:
z¼13.581, p¼ .008).
Linear regression analyses indicated that there was a signiﬁcant
effect of age on the increment scores on both Fazekas subscales
(PVH: R2¼ .17, F(1, 78)¼16.37, po .001; DWMH: R2¼ .17, F(1, 78)¼
16.09, po .001). As stated above, the patients in the meningioma
group were signiﬁcantly older than the other three groups. To test
if the severity of WM changes can be attributed to differences in
age we calculated a decrement score for each patient. A decrement
score was deﬁned as the patients’ observed white matter score oneach Fazekas scales minus their predicted white matter scores
based on the results of the linear regression analyses. The decre-
ment scores were then used to compare the white matter changes
between the four aetiologies subgroups using Kruskal–Wallis non
parametric ANOVA. After accounting for age, no signiﬁcant dif-
ference was found between the four aetiologies in both periven-
tricular hyper/hypo intensity (PVH) and deep white matter hyper/
hypo intensity signal (DWMH) sub-scales (PVH: χ2 (3, N¼80)¼
4.267, p¼ .234; DWMH: χ2 (3, N¼80)¼2.580, p¼ .461). This in-
dicated that differences between the aetiology subgroups in the
severity of WM changes can be attributed to differences in the
ages of the aetiology subgroups.
3.6. Neuropsychological performance of left and right frontal
patients
We compared the performance of left and right frontal patients
on the neuropsychological tests. Age and NART IQ signiﬁcantly
affected performance on RAPM (F(1, 66)¼14.018, po .001, ηp
2¼ .175 and F(1, 66)¼10.203, p¼ .002, ηp2¼ .134, respectively),
Stroop Test (F(1, 53)¼57.464, po .001, ηp2¼ .520 and F(1, 53)¼
7.473, p¼ .008, ηp2¼ .124, respectively) and Letter Fluency ‘S’ Test (F
(1, 82)¼14.630, po .001, ηp2¼ .151 and F(1,82)¼12.674, p¼ .001, ηp
2¼ .134, respectively). There was a signiﬁcant effect of age on Trail
Making Test Part B (F(1, 58)¼34.298, po .001, ηp2¼ .372). There
was a signiﬁcant effect of NART IQ on GNT score (F(1, 87)¼83.484,
po .001, ηp2¼ .490).
We found no signiﬁcant main effect of group (left frontal vs
right frontal) for the RAPM (F(1, 66)¼ .043, p¼ .837, ηp2¼ .001),
Letter Fluency ‘S’ Test (F(1, 82)¼1.328, p¼ .252, ηp2¼ .016), Trail
Making Test Part B (F(1, 58)¼1.84, p¼ .18, ηp2¼ .031) and the GNT
(F(1, 87)¼ .734, p¼ .394, ηp2¼ .008). However, a signiﬁcant group
effect was found on the Stroop Test (F(1, 53)¼13.348, p¼ .001, ηp
2¼ .201), reﬂecting worse performance of the left frontal patients
than right frontal patients (see Table 3), as often reported (for a
meta-analysis see Demakis (2004)).
3.7. Neuropsychological results: Performance of patients with dif-
ferent aetiologies
We compared the performance of the four different aetiology
subgroups (CVA, LGT, HGT and Meningioma) on the ﬁve neu-
ropsychological tests (RAPM, Stroop Test, Letter Fluency ‘S’ Test,
Trail Making Test Part B and GNT).
RAPM. There were signiﬁcant effects of age and NART IQ on
patients' performance on the RAPM (F(1, 64)¼13.328, p¼ .001, ηp
2¼ .172 and F(1, 64)¼14.177, po .001, ηp2¼ .181, respectively).
However, there was no main effect of group, with no signiﬁcant
difference in the neuropsychological performance of the four ae-
tiology subgroups (F(3, 64)¼1.578, p¼ .203, ηp2¼ .069, see Fig. 2a).
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Fig. 2. Performance of on the four frontal tasks for each of the four different aetiologies. Mean scores of the four aetiology subgroups on the four frontal tests not accounting
for age and NART IQ: (a) Raven's Advanced Progressive Matrices, (b) Stroop Colour Word Task, (c) Letter Fluency ’S’, (d) Trail Making Test Part B. Error Bars represent 71
standard error.
Table 4
Regression analyses for each neuropsychological test with age and NART IQ as
predictor variables.
Test Model Age NART
R2 P-value Beta (SE) P-value Beta (SE) P-value
RAPM .265 o .001  .067 (.018) o .001 .072 (.022) .002
Stroop .488 o .001 .126 (.018) o .001  .063 (.023) .008
Fluency ‘S’ .242 o .001  .149 (.039) o .001 .191 (.052) o .001
Trail B .390 o .001 .009 (.001) o .001  .004 (.002) .044
GNT .489 o .001  .003 (.004) .427  .047 (.005) o .001
NART¼National Adult Reading Test; RAPM¼Raven's Advanced Progressive Matrices;
GNT¼Graded Naming Test; 71 standard error are presented in parentheses;
R2¼variance accounted for when age and NART are both used as predictors.
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mance (F(1, 51)¼31.623, po .001, ηp2¼ .383 and F(1, 51)¼6.541,
p¼ .014, ηp2¼ .114, respectively). Again we found no main effect of
group, with no signiﬁcant difference in performance between the
four aetiology subgroups (F(3, 51)¼ .199, p¼ .896, ηp2¼ .012, see
Fig. 2b).
Letter Fluency ‘S’ Test. Age and NART IQ signiﬁcantly affected
performance (F(1, 80)¼8.078, p¼ .006, ηp2¼ .092 and F(1, 80)¼
11.378, p¼ .001, ηp2¼ .125, respectively). Again there was no main
effect of group, with no signiﬁcant difference in performance be-
tween the four aetiology subgroups (F(3, 80)¼ .319, p¼ .812,
ηp2¼ .012, see Fig. 2c).
Trail Making Test Part B. Age signiﬁcantly affected perfor-
mance (F(1, 56)¼21.767, po .001, ηp2¼ .280). NART IQ trended
towards signiﬁcantly affecting performance (F(1, 56)¼3.506,
p¼ .066, ηp2¼ .059). There was no signiﬁcant difference in perfor-
mance on this task between the four aetiologies after accounting
for age and NART IQ scores (F(3, 56)¼1.796, p¼ .158, ηp2¼ .088, see
Fig. 2d).
Graded Naming Test. Only NART IQ was found to signiﬁcantly
affect performance (F(1, 85)¼82.171, po .001, ηp2¼ .492). There
was no main effect of group, with no signiﬁcant difference in
performance between the four aetiology subgroups (F(3, 85)¼
2.02, p¼ .117, ηp2¼ .067).
3.7.1. Cognitive performance of the patients’ subsample within
volumetric analysis
We also compared the cognitive performance of the subsample
of 52 patients for whom we conducted a volumetric lesion ana-
lysis. Similarly to the results reported above, we found nosigniﬁcant difference across the four different aetiology groups on
the ﬁve neuropsychological tests (RAPM: F(3, 29)¼ .390, p¼ .761,
ηp2¼ .039; Stroop Colour-Word test: F(3, 26)¼ .855, p¼ .477,
ηp2¼ .09; Letter Fluency ‘S’: F(3, 38)¼ .447, p¼ .721, ηp2¼ .034;
Trails Making test Part B: F(3, 28)¼2.226, p¼ .107, ηp2¼ .193; GNT:
F(3, 41)¼ .526, p¼ .667, ηp2¼ .037).
3.8. Investigation of the effects of age and premorbid IQ on cognitive
performance
The previous analyses demonstrated that age and NART IQ have
a signiﬁcant effect on patients' performance. To further examine
this, linear regression analyses were performed on all tests, using
age and NART IQ as predictor variables. The results indicated that
age and NART IQ combined signiﬁcantly predicted performance on
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accounted for variance in the four frontal executive tests but not in
the GNT, a test of nominal function. NART IQ was a signiﬁcant
predictor of performance on all cognitive tests (see Table 4).
3.9. Speciﬁc aetiology subgroups analysis
We conducted three more speciﬁc analyses comparing aetiol-
ogies. Two of these analyses were used to compare our data with
previous studies (Anderson et al., 1990; Hom and Reitan, 1984).
3.9.1. Performance of CVA and tumour (LGT, HGT and meningioma)
patients
In accordance with Anderson et al. (1990), the performance of
the CVA patients was compared with a combined group of all
tumour patients (LGT, HGT and meningioma). Laterality of lesion
was added as an additional independent variable since Anderson
et al. (1990) reported that following left hemisphere damage
stroke patients performed signiﬁcantly poorer than tumour pa-
tients on selected subtests of the Multilingual Aphasia Examina-
tion Battery. We found a signiﬁcant effect of age and NART IQ on
the RAPM (F(1, 64)¼14.366, po .001, ηp2¼ .183 and F(1, 64)¼
9.007, p¼ .004, ηp2¼ .123, respectively) Stroop Colour-Word Test (F
(1, 51)¼56.404, po .001, ηp2¼ .525 and F(1, 51)¼7.825, p¼ .007,
ηp2¼ .133, respectively), Letter Fluency ‘S’ Test (F(1, 80)¼13.907,
po .001, ηp2¼ .148 and F(1, 80)¼12.245, p¼ .001, ηp2¼ .133, re-
spectively). There was a signiﬁcant effect of age on performance on
Trail Making Test Part B (F(1, 56)¼35.586, po .001, ηp2¼ .389). On
the GNT, there was a signiﬁcant effect of NART IQ on performance
(F(1, 85)¼81.975, po .001, ηp2¼ .491).
We found no main effect of group, with no signiﬁcant differ-
ence in performance between CVA and tumour aetiology sub-
groups on the RAPM (F(1, 64)¼ .138, p¼ .711, ηp2¼ .002); Stroop
Colour-Word Test (F(1, 51)¼ .450, p¼ .506, ηp2¼ .009); and Letter
Fluency ‘S’ Test (F(1, 80)¼ .226, p¼ .636, ηp2¼ .003). We found a
signiﬁcant difference in the performance of CVA and tumour pa-
tients on the Trail Making Test Part B (F(1, 56)¼4.890, p¼ .031,
ηp2¼ .08) and a non-signiﬁcant trend on the GNT (F(1, 85)¼3.202,
p¼ .077, ηp2¼ .036). Given these two latter results we conducted
post-hoc analyses for the Trail Making Part B and GNT tests
comparing the performance of the CVA patients with each tumour
subgroup. We found no signiﬁcant difference in Trail Making part
B and GNT tests' performance between CVA and LGT (Trail Making
Test Part B, F(1, 31)¼2.443, p¼ .128, ηp2¼ .073; GNT (F(1, 43)¼
2.808, p¼ .101, ηp2¼ .061). Similarly we found no signiﬁcant dif-
ference between CVA and meningioma’s in performance on the
Trail making test B and on the GNT (F(1, 29)¼2.203, p¼ .149,
ηp2¼ .071 and F(1, 46)¼ .369, p¼ .547, ηp2¼ .008). However we
found a signiﬁcant difference between CVA and HGT in perfor-
mance on the GNT (F(1, 40)¼5.335, p¼ .026, ηp2¼ .118) and a non-
signiﬁcant trend on the Trail Making Test Part B (F(1, 30)¼3.223,
p¼ .083, ηp2¼ .097; suggesting that the CVA patients performed
worse than HGT on these two tests.
We found no main effect of laterality, with no difference in the
performance of left and right frontal patients on the RAPM
(F(1, 64)¼ .230, p¼ .633, ηp2¼ .004), Letter Fluency ‘S’ Test
(F(1, 80)¼ .731, p¼ .395, ηp2¼ .009), Trail Making Test Part B
(F(1, 56)¼ .804, p¼ .374, ηp2¼ .014), the GNT (F(1, 85)¼ .200,
p¼ .656, ηp2¼ .002). The only exception was the Stroop Colour-
Word Test (F(1, 51)¼13.654, p¼ .001, ηp2¼ .211) where left frontal
patients performed worse than right frontal patients.
We found no signiﬁcant interactions between aetiology and
laterality on any neuropsychological tasks (RAPM: F(1, 64)¼ .449,
p¼ .505, ηp2¼ .007; Stroop Colour-Word Test: F(1, 51)¼ .741,
p¼ .393, ηp2¼ .014; Letter Fluency ‘S’ Test: F(1,80)¼ .048, p¼ .826,
ηp2¼ .001; Trail Making Test Part B: F(1, 56)¼1.477, p¼ .229,ηp2¼ .026; and GNT: F(1, 85)¼ .129, p¼ .720, ηp2¼ .002).
3.9.2. Performance of LGT and HGT patients
The performance of the LGT and HGT patients was compared
(Hom and Reitan, 1984). There was a signiﬁcant effect of NART IQ
on performance on the RAPM (F(1, 24)¼5.95, p¼ .022, ηp2¼ .199),
Stroop Colour-Word Test (F(1, 23)¼4.839, p¼ .038, ηp2¼ .174),
Letter Fluency ‘S’ Test (F(1, 36)¼8.526, p¼ .006, ηp2¼ .191), Trail
Making Test Part B (F(1, 25)¼10.06, p¼ .004, ηp2¼ .287) and GNT (F
(1, 37)¼24.867, po .001, ηp2¼ .402). For all neuropsychological
tests, there was no main effect of group, with no signiﬁcant dif-
ference in performance between LGT and HGT aetiology sub-
groups: Stroop Colour-Word Test (F(1, 23)¼ .480, p¼ .495,
ηp2¼ .02), Letter Fluency ‘S’ Test (F(1,36)¼ .38, p¼ .542, ηp2¼ .01),
Trail Making Test Part B (F(1, 25)¼ .246, p¼ .624, ηp2¼ .01), GNT
(F(1, 37)¼ .516, p¼ .477, ηp2¼ .014). However there was a trend
towards signiﬁcance for the RAPM (F(1, 24)¼3.318, p¼ .081,
ηp2¼ .121).
3.9.3. Performance of LGT, HGT and meningioma patients
The performance of the LGT, HGT and Meningioma patients was
compared. There was a signiﬁcant effect of age and NART IQ on
performance on the RAPM (F(1, 45)¼6.204, p¼ .017, ηp2¼ .121 and
F(1, 45)¼12.945, p¼ .001, ηp2¼ .223, respectively), the Stroop Col-
our-Word Test (F(1, 34)¼9.378, p¼ .004, ηp2¼ .216 and F(1, 34)¼
8.849, p¼ .005, ηp2¼ .207, respectively), Letter Fluency ‘S’ Test
(F(1, 57)¼5.778, p¼ .019, ηp2¼ .092 and F(1, 57)¼10.682, p¼ .002,
ηp2¼ .158, respectively) and Trail Making Test Part B (F(1, 37)¼
7.510, p¼ .009, ηp2¼ .169 and F(1, 37)¼5.716, p¼ .022, ηp2¼ .134,
respectively). On the GNT, there was only a signiﬁcant effects of
NART IQ on performance (F(1, 61)¼58.917, po .001, ηp2¼ .491). For
all neuropsychological tests, there was no main effect of group,
with no signiﬁcant difference in performance between the three
aetiology subgroups on the RAPM (F(2, 45)¼2.224, p¼ .120,
ηp2¼ .09), Stroop Colour-Word Test (F(2, 34)¼ .182, p¼ .835,
ηp2¼ .011), Letter Fluency ‘S’ Test (F(2, 57)¼ .168, p¼ .845, ηp
2¼ .006), Trail Making Test Part B (F(2, 37)¼ .142, p¼ .868, ηp
2¼ .008) and GNT (F(2, 61)¼ .849, p¼ .433, ηp2¼ .027).4. Discussion
To the best of our knowledge, our retrospective study of a large
sample of frontal patients is the ﬁrst to compare cognitive per-
formance across four different aetiologies. The frontal patients'
lesions were conﬁned to the left or right frontal lobe and perfor-
mance was assessed with four frontal executive tasks and one
nominal task. Thus, our comparison of cognitive performance is
less affected by variability in lesion location than earlier studies.
Our four aetiology subgroups (CVA, high or low grade tumour and
meningioma) did not differ in handedness, gender, education or
premorbid intelligence. There was a signiﬁcant effect of age, with
LGT patients being somewhat younger and meningioma patients
signiﬁcantly older. This is in keeping with the literature reporting
that LGT generally affects younger adults (mean age of occurrence
of 35 years; e.g. Behin et al. (2003)), whilst meningiomas generally
affect older adults (mean age of diagnosis of 56 years; e.g. Milker-
Zabel and Debus, (2008).
We found no signiﬁcant difference across the four aetiologies in
the number of patients with damage to lateral (left and right),
medial and orbitofrontal regions. Similarly, no signiﬁcant differ-
ence across the four aetiologies was found in the total frontal le-
sion volumes or the amount of global brain atrophy. We did ﬁnd
signiﬁcantly more white matter changes in the meningioma group.
However, when we compared white matter changes, after ac-
counting for age, no signiﬁcant difference between the aetiology
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white matter changes is most likely due to age-related changes.
Indeed it is known that age is associated with an increase in white
matter changes (e.g. Xiong and Mok, 2011).
We found that the four aetiology subgroups did not sig-
niﬁcantly differ in their performance on four ‘frontal’ executive
test (RAPM, Stroop Test, Trail Making Test Part B, Letter Fluency ‘S’)
and on a nominal test (GNT). A previous study on a rather small
sample of patients with frontal lobe epilepsy similarly reported no
effect of aetiology on frontal tasks (Upton and Thompson, 1997). Of
course, in considering non-signiﬁcant results one always has the
issue of statistical power. Our group size of 100 frontal patients is
larger than that of the three typical ‘frontal’ studies quoted in the
introduction (Stuss et al., 2003; Roca et al., 2010; Robinson et al.,
2012). Furthermore, the effect sizes we reported suggest that a
vastly larger patient sample would be needed to observe any po-
tential differences in the neuropsychological performance be-
tween aetiologies. For example, based a power of .8, α¼ .05 and on
the effect size obtained in the current study, 902 patients
would have been needed to achieve a signiﬁcant effect of aetiology
on the Stroop task (using the method prescribed by Faul et al.
(2007)).
Interestingly, while not ﬁnding an effect of aetiology on cog-
nitive performance, we did document a signiﬁcant effect of pre-
morbid IQ on all cognitive tasks and a signiﬁcant effect of age on
the four frontal executive tests. In keeping with our current ﬁnd-
ings, a decline in performance on frontal ‘executive’ tasks has been
reported in healthy aging and in patients with head injury (Ardila
and Rosselli, 1989; Whelihan and Lesher, 1985; Raymont et al.,
2008; Senathi-Raja et al., 2010). This supports the hypothesis that
cognitive processes supported by the frontal lobes are among the
ﬁrst to decline with age (Albert and Kaplan, 1980; Daigneault et al.,
1992; Dempster, 1992). Thus when comparing across aetiologies it
is important to account for age because of the known differences
between the aetiologies in the age of onset (for example see Behin
et al. (2003)).
We conducted three more focused analyses comparing speciﬁc
aetiology subgroups directly. These comparisons have been pre-
viously carried out by others, although no previous studies com-
pared all four aetiologies, with all tumours at the post-operative
stage. We ﬁrst compared CVA and tumours. Again, no signiﬁcant
difference between aetiologies was found in performance on all
but one of the neuropsychological test. The only exception was
found on Trail-Making Test part B; however, this result would not
survive Bonferroni correction since there is no a priori reason to
assume that aetiology should affect only this particular executive
test. The lack of difference in performance across CVA and tumours
is in contrast with the only study which directly compared these
two aetiologies (Anderson et al., 1990). Notably, Anderson and
colleagues’ did not control for the effect of age, even though their
CVA patients were older than their tumour patients. This raises the
possibility that their reported differences on neuropsychological
test performance may be due to the older age of CVAs, rather than
to differences in aetiology. When the effect of age is controlled for,
as in our study, the performance of CVA and Tumour patients
tended not to show signiﬁcant effects.
Secondly, we compared the neuropsychological performance of
the LGT and HGT groups. We found no signiﬁcant difference in
cognitive performance between the tumour types. The only ex-
ception was a non-signiﬁcant trend with LGT tending to perform
worse on the RAPM. Two previous studies also reported no sig-
niﬁcant difference in performance between LGT and HGT patients,
at the post-operative stage of treatment (Scheibel et al., 1996;
Talacchi et al., 2011). In other studies, complex patterns of aetiol-
ogy effects have been reported with usually poorer cognitive
performance associated with HGT (e.g. Shallice et al., 2010;Talacchi et al., 2011). It is possible that some but not all of the
previously reported differences in performance between high and
low grade tumours may have been due to patients being at the
preoperative or postoperative stage rather than to different tu-
mour types (e.g. Hahn et al., 2003; Hom and Reitan, 1984; but see
Shallice et al. (2010)). Pre-operatively, low and high grade tumours
may recruit mechanisms of neural plasticity in different ways,
leading to different functional outcomes. For example, functional
networks in low grade but not high grade tumours have been
shown to differ from healthy controls, possibly reﬂecting differ-
ences in plasticity when compensating for different lesion growth
patterns (Van Dellen et al., 2012).
In the literature it has been debated whether the grouping of
patients with different neurological aetiologies is methodologi-
cally appropriate for the purpose of neuropsychological in-
vestigation. When investigating neuro-cognitive architecture it is
critical to have sizeable groups of patients so sufﬁcient power can
be obtained to search for signiﬁcant effects. Our main result in-
dicated that after accounting for the signiﬁcant effects of age and
premorbid IQ on cognitive performance there were no signiﬁcant
differences between frontal patients of different aetiologies. This
result suggests that the grouping together of patients with dif-
ferent aetiologies but similar site and size of lesions is a pragmatic
procedure that helps to make this possible. In our view any aver-
aging procedure of neuropsychological patients is liable to suffer
from potential artefacts, but to eliminate all possible artefacts
makes it impossible in practise to obtain useful results. One must
balance the danger of artefacts with the utility of increased sample
size. Our study has established that combining across vascular and
different types of tumour pathologies is not likely to produce a
major distortion in the pattern of neuropsychological perfor-
mance, at least for frontal patients. Our results therefore suggest
that grouping patients with focal frontal lesions caused by differ-
ent aetiologies is a pragmatically justiﬁed methodological ap-
proach that can help to further the understanding of the organi-
sation of frontal executive functions.Acknowledgments
This work was supported by the Wellcome Trust Grant
(089231/A/09/Z). We are grateful for the invaluable help of Drs
Gail Robinson, Sarah E. MacPherson and Martha Turner for testing
some of the patients included in this study. This work was un-
dertaken at UCLH/UCL, which received a proportion of funding
from the Department of Health's National Institute for Health
Research Biomedical Research Centre's funding scheme.References
Albert, M.S., Kaplan, E., 1980. Organic implications of neuropsychological deﬁcits in
the elderly. New Directions in Memory and Aging, pp. 403–432.
Anderson, S.W., Damasio, H., Tranel, D., 1990. Neuropsychological impairments
associated with lesions caused by tumour or stroke. Arch. Neurol. 47 (4),
397–405.
Ardila, A., Rosselli, M., 1989. Neuropsychological characteristics of normal aging.
Dev. Neuropsychol. 5 (4), 307–320.
Behin, A., Hoang-Xuan, K., Carpentier, A.F., Delattre, J.Y., 2003. Primary brain tu-
mours in adults. Lancet 361 (9354), 323–331.
Benton, A.L., 1968. Differential behavioural effects in frontal lobe disease. Neu-
ropsychologia 6 (1), 53–60.
Brambati, S.M., Myers, D., Wilson, A., Rankin, K.P., Allison, S.C., Rosen, H.J., Gorno-
Tempini, M.L., 2006. The anatomy of category-speciﬁc object naming in neu-
rodegenerative diseases. J. Cognit. Neurosci. 18 (10), 1644–1653.
Campanella, F., D’Agostini, S., Skrap, M., Shallice, T., 2010. Naming manipulable
objects: anatomy of a category speciﬁc effect in left temporal tumours. Neu-
ropsychologia 48 (6), 1583–1597.
Daigneault, S., Braün, C.M., Whitaker, H.A., 1992. An empirical test of two opposing
theoretical models of prefrontal function. Brain Cogn. 19 (1), 48–71.
L. Cipolotti et al. / Neuropsychologia 68 (2015) 21–3030de Leeuw, F.E., de Groot, J.C., Achten, E., Oudkerk, M., Ramos, L.M., Heijboer, R.,
Hofman, A., Jolles, J., van Gijn, J., Breteler, M.M., 2001. Prevalence of cerebral
white matter lesions in elderly people: a population based magnetic resonance
imaging study. The Rotterdam Scan Study. J. Neurol. Neurosurg. Psychiatry 70
(1), 9–14.
Demakis, G.J., 2004. Frontal lobe damage and tests of executive processing: a meta-
analysis of the category test, stroop test, and trail-making test. J. Clin. Exp.
Neuropsychol. 26 (3), 441–450.
Dempster, F.N., 1992. The rise and fall of the inhibitory mechanism: toward a
uniﬁed theory of cognitive development and aging. Dev. Rev. 12 (1), 45–75.
Duffau, H., 2011. Re: clinical neuroanatomy: [discussion forum]. Cortex 47 (8),
1016–1017.
Duvernoy, H.M., Cabanis, E.A., Bourgouin, P., 1991. The Human Brain: Surface,
Three-dimensional Sectional Anatomy and MRI. Springer Verlag, Wien.
Faul, F., Erdfelder, E., Lang, A.G., Buchner, A., 2007. Gn Power 3: A ﬂexible statistical
power analysis program for the social, behavioural, and biomedical sciences.
Behav. Res. Methods 39 (2), 175–191.
Fazekas, F., Chawluk, J.B., Alavi, A., Hurtig, H.I., Zimmerman, R.A., 1987. MR signal
abnormalities at 1.5 T in Alzheimer's dementia and normal aging. Am. J.
Roentgenol. 149 (2), 351–356.
Hahn, C.A., Dunn, R.H., Logue, P.E., King, J.H., Edwards, C.L., Halperin, E.C., 2003.
Prospective study of neuropsychological testing and quality-of-life assessment
of adults with primary malignant brain tumours. Int. J. Radiat. Oncol. Biol. Phys.
55 (4), 992–999.
Hom, J., Reitan, R.M., 1984. Neuropsychological correlates of rapidly vs. slowly
growing intrinsic cerebral neoplasms. J. Clin. Exp. Neuropsychol. 6 (3), 309–324.
Jääskeläinen, J., Servo, A., Haltia, M., Wahlström, T., Valtonen, S., 1985. Intracranial
hemangiopericytoma: radiology, surgery, radiotherapy, and outcome in 21
patients. Surg. Neurol. 23 (3), 227–236.
Karnath, H.O., Steinbach, J.P., 2011. Do brain tumours allow valid conclusions on the
localisation of human brain functions? – Objections. Cortex 47 (8), 1004–1006.
Kim, C.K., Lee, S.H., Kim, B.J., Ryu, W.S., Yoon, B.W., 2011. Age-independent asso-
ciation of pulse pressure with cerebral white matter lesions in asymptomatic
elderly individuals. J. Hypertens. 29 (2), 325–329.
Kleihues, P., Burger, P.C., Aldape, K., Brat, D.J., Biernat, W., Bigner, D.D., Cevenee, W.
K., 2007. WHO Classiﬁcation of Tumors of the Central Nervous System.
Krainik, A., Lehericy, S., Duffau, H., Capelle, L., Chainay, H., Cornu, P., Marsault, C.,
2003. Postoperative speech disorder after medial frontal surgery: role of the
supplementary motor area. Neurology 60 (4), 587–594.
MacPherson, S.E., Bozzali, M., Cipolotti, L., Dolan, R.J., Rees, J.H., Shallice, T., 2008.
Effect of frontal lobe lesions on the recollection and familiarity components of
recognition memory. Neuropsychologia 46 (13), 3124–3132.
MacPherson, S.E., Turner, M.S., Bozzali, M., Cipolotti, L., Shallice, T., 2010. Frontal
subregions mediating Elevator Counting task performance. Neuropsychologia
48 (12), 3679–3682.
McKenna, P., Warrington, E.K., 1980. Testing for nominal dysphasia. J. Neurol.
Neurosurg. Psychiatry 43 (9), 781–788.
Milker-Zabel, S., Debus, J., 2008. Meningioma. In M. H. Seegenschmiedt, HB. Ma-
koski, KR. Trott and L. W. Brady (Eds.): Radiotherapy for Non-Malignant Dis-
orders. Springer, Berlin Heidelberg, pp. 609–628.
Murphy, P., Shallice, T., Robinson, G., MacPherson, S.E., Turner, M., Woollett, K.,
Cipolotti, L., 2013. Impairments in proverb interpretation following focal frontal
lobe lesions. Neuropsychologia 51 (11), 2075–2086.Nelson, H.E., 1982. National Adult Reading Test (NART): For the Assessment of
Premorbid Intelligence in Patients with Dementia: Test Manual, NFER.
Perry, A., Louis, D., Scheithauer, B., Budka, H., von Deimling, A., 2007. World Health
Organization Classiﬁcation of Tumours.
Raven, J.C., 1965. Advanced Progressive Matrices, Sets I and II.. H.K. Lewis, London.
Raymont, V., Greathouse, A., Reding, K., Lipsky, R., Salazar, A., Grafman, J., 2008.
Demographic, structural and genetic predictors of late cognitive decline after
penetrating head injury. Brain 131 (2), 543–558.
Reitan, R.M. and Wolfson, D., 1985. The Halstead–Reitan Neuropsycholgical Test
Battery: Therapy and clinical interpretation. Neuropsychological Press; Tucson,
AZ.
Robinson, G., Shallice, T., Bozzali, M., Cipolotti, L., 2012. The differing roles of the
frontal cortex in ﬂuency tests. Brain 135 (7), 2202–2214.
Roca, M., Parr, A., Thompson, R., Woolgar, A., Torralva, T., Antoun, N., Duncan, J.,
2010. Executive function and ﬂuid intelligence after frontal lobe lesions. Brain
133 (1), 234–247.
Scheibel, R.S., Meyers, C.A., Levin, V.A., 1996. Cognitive dysfunction following sur-
gery for intracerebral glioma: inﬂuence of histopathology, lesion location, and
treatment. J. Neurooncol. 30 (1), 61–69.
Scheltens, P., Pasquier, F., Weerts, J.G.E., Barkhof, F., Leys, D., 1997. Qualitative as-
sessment of cerebral atrophy on MRI: inter-and intra-observer reproducibility
in dementia and normal aging. Eur. Neurol. 37 (2), 95–99.
Senathi-Raja, D., Ponsford, J., Schönberger, M., 2010. Impact of age on long-term
cognitive function after traumatic brain injury. Neuropsychology 24 (3), 336.
Shallice, T., Mussoni, A., D’Agostino, S., Skrap, M., 2010. Right posterior cortical
functions in a tumour patient series. Cortex 46 (9), 1178–1188.
Stuss, D.T., Alexander, M.P., Hamer, L., Palumbo, C., Dempster, R., Binns, M., Izukawa,
D., 1998. The effects of focal anterior and posterior brain lesions on verbal
ﬂuency. J. Int. Neuropsychol. Soc. 4 (3), 265–278.
Stuss, D.T., Murphy, K.J., Binns, M.A., Alexander, M.P., 2003. Staying on the job: the
frontal lobes control individual performance variability. Brain 126 (11),
2363–2380.
Stuss, D.T., Alexander, M.P., 2005. Does damage to the frontal lobes produce im-
pairment in memory? Curr. Dir. Psychol. Sci. 14 (2), 84–88.
Talacchi, A., Santini, B., Savazzi, S., Gerosa, M., 2011. Cognitive effects of tumour and
surgical treatment in glioma patients. J. Neurooncol. 103 (3), 541–549.
Trenerry, M.R., Crosson, B., DeBoe, J., Leber, W.R., 1989. Stroop Neuropsychological
Screening Test. Psychological Assessment Resources, Odessa, FL.
Turner, M.S., Cipolotti, L., Yousry, T., Shallice, T., 2007. Qualitatively different
memory impairments across frontal lobe subgroups. Neuropsychologia 45 (7),
1540–1552.
Upton, D., Thompson, P.J., 1997. Neuropsychological test performance in frontal-
lobe epilepsy: the inﬂuence of aetiology, seizure type, seizure frequency and
duration of disorder. Seizure 6 (6), 443–447.
Van Dellen, E., Douw, L., Hillebrand, A., Ris-Hilgersom, I.H., Schoonheim, M.M.,
Baayen, J.C., Reijneveld, J.C., 2012. MEG network differences between low-and
high-grade glioma related to epilepsy and cognition. PloS One 7 (11), e50122.
Whelihan, W.M., Lesher, E.L., 1985. Neuropsychological changes in frontal functions
with aging. Dev. Neuropsychol. 1 (4), 371–380.
Xiong, Y.Y., Mok, V., 2011. Age-related white matter changes. J. Aging Res. 2011,
13–25.
